New developments in the biology of fibroblast growth factors

DM Ornitz, N Itoh - WIREs mechanisms of disease, 2022 - Wiley Online Library
The fibroblast growth factor (FGF) family is composed of 18 secreted signaling proteins
consisting of canonical FGFs and endocrine FGFs that activate four receptor tyrosine …

Fibroblast growth factor control of cartilage homeostasis

MB Ellman, D Yan, K Ahmadinia… - Journal of cellular …, 2013 - Wiley Online Library
Osteoarthritis (OA) and degenerative disc disease (DDD) are similar diseases involving the
breakdown of cartilage tissue, and a better understanding of the underlying biochemical …

The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma

MJ McBride, JL Pulice, HC Beird, DR Ingram… - Cancer cell, 2018 - cell.com
Synovial sarcoma (SS) is defined by the hallmark SS18-SSX fusion oncoprotein, which
renders BAF complexes aberrant in two manners: gain of SSX to the SS18 subunit and …

The SS18-SSX oncoprotein hijacks KDM2B-PRC1. 1 to drive synovial sarcoma

A Banito, X Li, AN Laporte, JS Roe, F Sanchez-Vega… - Cancer cell, 2018 - cell.com
Synovial sarcoma is an aggressive cancer invariably associated with a chromosomal
translocation involving genes encoding the SWI-SNF complex component SS18 and an SSX …

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy

TO Nielsen, NM Poulin, M Ladanyi - Cancer discovery, 2015 - AACR
Oncogenesis in synovial sarcoma is driven by the chromosomal translocation t (X, 18; p11,
q11), which generates an in-frame fusion of the SWI/SNF subunit SS18 to the C-terminal …

Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers

LM Brown, PG Ekert, EDG Fleuren - Oncogene, 2023 - nature.com
Rare but recurrent mutations in the fibroblast growth factor receptor (FGFR) pathways, most
commonly in one of the four FGFR receptor tyrosine kinase genes, can potentially be …

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential

P Francis, HM Namløs, C Müller, P Edén, J Fernebro… - BMC genomics, 2007 - Springer
Background Soft tissue sarcoma (STS) diagnosis is challenging because of a multitude of
histopathological subtypes, different genetic characteristics, and frequent intratumoral …

Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor

CR Antonescu, L Zhang, GP Nielsen… - Genes …, 2011 - Wiley Online Library
Despite their shared predilection for superficial soft tissue of distal extremities and frequent
local recurrences, myxoinflammatory fibroblastic sarcoma (MIFS) and hemosiderotic …

Anticancer molecules targeting fibroblast growth factor receptors

G Liang, Z Liu, J Wu, Y Cai, X Li - Trends in pharmacological sciences, 2012 - cell.com
The fibroblast growth factor receptor (FGFR) family includes four highly conserved receptor
tyrosine kinases: FGFR1–4. Upon ligand binding, FGFRs activate an array of downstream …

Two genetic pathways, t (1; 10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically …

KH Hallor, R Sciot, J Staaf… - The Journal of …, 2009 - Wiley Online Library
Myxoinflammatory fibroblastic sarcoma (MIFS) is a low‐grade malignant neoplasm for which
limited genetic information, including at (1; 10)(p22; q24) and amplification of chromosome 3 …